<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-R9LG1RYK</identifier><date>2016</date><creator>Bogataj, Marija</creator><creator>Hribar, Melita</creator><creator>Klančar, Uroš</creator><relation>documents/doc/R/URN_NBN_SI_doc-R9LG1RYK_001.pdf</relation><relation>documents/doc/R/URN_NBN_SI_doc-R9LG1RYK_001.txt</relation><format format_type="issue">4</format><format format_type="volume">67</format><format format_type="type">article</format><format format_type="extent">str. 235-241</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">4100209</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-R9LG1RYK</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">alternativne metode za testiranje sproščanja</subject><subject language_type_id="eng">drug</subject><subject language_type_id="slv">farmacevtske oblike</subject><subject language_type_id="slv">gastrointestinalna motaliteta</subject><subject language_type_id="slv">podaljšano sproščanje</subject><subject language_type_id="slv">zdravila</subject><title>Pomen razvoja alternativnih metod za testiranje sproščanja zdravilnih učinkovin iz farmacevtskih oblik s podaljšanim sproščanjem</title><title>The importance of developing the alternative methods for testing the drug dissolution from extended release formulations</title></Record>